Astrazeneca PLC (NYSE:AZN)‘s stock had its “neutral” rating reiterated by JPMorgan Chase & Co. in a research report issued on Sunday. Other hedge funds and institutional investors recently modified their holdings of the company. Logan Capital Management Inc. increased its position in shares of Astrazeneca PLC by 0.6% in the first quarter. Logan Capital Management […]
